Why is MLYS Down Today?
About Mineralys Therapeutics, Inc. Common Stock
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that ...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.4%
Market Comparison
Quick Trade Ideas
Options strategies to consider for MLYS's -6% move
No Options Available
MLYS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get MLYS Alerts
We'll notify you when MLYS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
MLYS has moved more than 3.0% down on 40 occasions in the past year.
Frequently Asked Questions
Why is MLYS stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.4% on average.
Is MLYS stock a buy or sell right now?
Based on current analysis, MLYS shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the MLYS stock price target?
MLYS is currently trading at $23.74. Based on today's momentum, the expected short-term range is $23.02 - $24.21. See long-term price prediction →
Will MLYS stock continue falling?
Our analysis shows a 45% probability that MLYS's move continues in the next 1-3 days. Key level to watch: $22.55 (support).
Is MLYS stock oversold or overbought?
MLYS's RSI (Relative Strength Index) is currently at 35.5. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for MLYS stock?
MLYS's 10-day momentum indicator is at -4.26. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is MLYS outperforming or underperforming the market?
MLYS (-5.55%) is currently significantly underperforming the market (-5.7% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for MLYS?
MLYS's MACD (-0.68) is currently below the signal line (-0.15), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 16.2) is weak.
Is MLYS in an uptrend or downtrend?
Based on moving average analysis, MLYS is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $27.65, 50-day SMA: $26.93.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis